Contact
searchSearch
HMP Global

Volume 19 - Issue 7 - July 2022

Original Research
The Value of Clinical Risk Factors and Inflammatory Biomarkers in Isolated Coronary Artery Ectasia: A Cross-Sectional Study From a Tertiary Center
07/19/2022
Betul Balaban Kocas, MD; Gokhan Cetinkal, MD; Suleyman Sezai Yildiz, MD; Kadriye Kilickesmez, MD
This study evaluated the association of atherosclerotic risk factors and inflammatory biomarkers with isolated coronary artery ectasia.
This study evaluated the association of atherosclerotic risk factors and inflammatory biomarkers with isolated coronary artery ectasia.
This study evaluated the...
07/19/2022
Vascular Disease Management
Case Report
Free Abdominopelvic Pus-Induced Mycotic Arterial False Aneurysms
07/15/2022
Christopher G. DuCoin, MD; Islam M. Ibrahim, MD; Abdul-Rhaman F. Diab, MD; Ali Lattouf, MD; Sharique Nazir, MD; Joseph A. Sujka, MD
A case of lumbar and internal iliac artery pseudoaneurysms following cecal perforation.
A case of lumbar and internal iliac artery pseudoaneurysms following cecal perforation.
A case of lumbar and internal...
07/15/2022
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Pulmonary Arterial Hypertension (PAH)
FDA Updates Winrevair Label With HYPERION Data in Newly Diagnosed PAH
09/23/2026
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling...
09/23/2026
Cath Lab Digest
Hand Protection
Mölnlycke Launches Biogel Radiation Protection Gloves to Tackle Low Adoption of Hand Protection in Radiation-Guided Surgical Procedures
09/22/2026
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC....
09/22/2026
Cath Lab Digest
TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Pulmonary Embolism
PRAGUE-26 Trial: Evaluating Catheter-Directed Thrombolysis for Intermediate-High Risk Pulmonary Embolism Patients Versus Standard Anticoagulation Therapy Alone
09/01/2026
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial...
09/01/2026
Cath Lab Digest
NYU Langone
NYU Langone Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
08/27/2026
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed...
08/27/2026
Vascular Disease Management
Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest
Imaging of acute ischemic stroke
Stroke Treatment
Siemens Healthineers Receives ARPA-H Funding of up to $31M to Advance Remote Endovascular Robotics for Acute Stroke Treatment
08/20/2026
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential...
08/20/2026
Cath Lab Digest
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management

July 2022

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use